Search results
Showing 3646 to 3660 of 8234 results
View a complete list of all our guidance, NICE advice and quality standards currently in development
Biographies for all current members of the diagnostics advisory committee.
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.
Our framework agreement allows UK NHS, health and social care organisations to buy knowledge resources that support practice, learning and development.
Check to see if you're entitled to access a range of content purchased by the NHS. If you are eligible, you can register for an OpenAthens account using our online form.
NHS OpenAthens accounts are managed by a network of administrators who can answer questions and offer support to users in England.
Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...
Our resource planner tool to help you plan for and implement NICE guidance.
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
Find out what guidance is being considered for development
Find out which guidance and quality standards are awaiting development
See a complete list of all our guidance and quality standards currently open for consultation
This indicator covers the percentage of patients with a new diagnosis of hypertension in the preceding 1 April to 31 March who have a record of a 12-lead ECG performed in the 3 months before or after the date of entry to the hypertension register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM77
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (HTG630)
Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1-2-3, DELFIA Xpress sFlt-1/PLGF 1-2-3 ratio, Elecsys immunoassay sFlt-1/PLGF ratio, Triage PLGF Test.